Erlotinib hydrochloride and Back pain aggravated - a phase IV clinical study of FDA data

Summary:

Back pain aggravated is reported as a side effect among people who take Erlotinib hydrochloride (erlotinib hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Hydrochlorothiazide, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Back pain aggravated when taking Erlotinib hydrochloride. It is created by eHealthMe based on reports of 4,643 people who have side effects when taking Erlotinib hydrochloride from the FDA, and is updated regularly.

What is Erlotinib hydrochloride?

Erlotinib hydrochloride has active ingredients of erlotinib hydrochloride. eHealthMe is studying from 4,663 Erlotinib hydrochloride users. Check the latest studies of Erlotinib hydrochloride.

What is Back pain aggravated?

Back pain aggravated is found to be associated with 3,358 drugs and 2,100 conditions by eHealthMe. Check the latest studies of Back pain aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

4,643 people reported to have side effects when taking Erlotinib hydrochloride.
Among them, 65 people (1.4%) have Back pain aggravated.

Could Erlotinib hydrochloride cause Back pain aggravated?

Among these 65 people:

How long have people been on Erlotinib hydrochloride when they have Back pain aggravated? *

What is the gender of people who have Back pain aggravated when taking Erlotinib hydrochloride? *

female: 60.66 %
male: 39.34 %

What is the age of people who have Back pain aggravated when taking Erlotinib hydrochloride? *

What are other drugs people take besides Erlotinib hydrochloride? *

What are other side effects people have besides Back pain aggravated? *

Diarrhea: 18 people, 27.69%
Rashes (redness): 17 people, 26.15%
Dyspnea (difficult or laboured breathing): 14 people, 21.54%
Anaemia (lack of blood): 13 people, 20.00%
Fall: 13 people, 20.00%
Pneumonia: 12 people, 18.46%
Pain: 11 people, 16.92%
Oedema Peripheral (superficial swelling): 11 people, 16.92%
Dehydration (dryness resulting from the removal of water): 11 people, 16.92%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 15.38%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 15 people, 23.08%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 9 people, 13.85%
Pain: 9 people, 13.85%
Pancreatic Carcinoma (pancreatic cancer): 8 people, 12.31%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 4 people, 6.15%
Adenocarcinoma Pancreas (cancer of pancreas): 4 people, 6.15%
Breast Cancer Metastatic: 4 people, 6.15%
Bronchial Carcinoma (lung cancer): 4 people, 6.15%
Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 6.15%
Diabetes: 3 people, 4.62%

* Approximation only. Some reports may have incomplete information.

Do you take Erlotinib hydrochloride and have Back pain aggravated?

- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erlotinib hydrochloride:

Erlotinib hydrochloride (4,663 reports)

Browse all side effects of Erlotinib hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain aggravated:

Back pain aggravated (3,358 drugs)

Browse all the conditions that are associated with Back pain aggravated:

Back pain aggravated (2,100 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erlotinib hydrochloride (the active ingredients of Erlotinib hydrochloride) and Erlotinib hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.